oltipraz has been researched along with Koch's Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lou, H; Ma, J; Shen, X; Sun, Q; Zhang, Q | 1 |
1 other study(ies) available for oltipraz and Koch's Disease
| Article | Year |
|---|---|
Activation of Nrf2 signaling by oltipraz inhibits death of human macrophages with mycobacterium tuberculosis infection.
Topics: Apoptosis; Cytoprotection; Humans; Macrophages; Necrosis; NF-E2-Related Factor 2; Oxidative Stress; Pyrazines; Signal Transduction; Thiones; Thiophenes; Tuberculosis | 2020 |